Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.230
-0.070 (-5.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Humacyte Stock Forecast
HUMA's stock price has decreased by -72.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Humacyte stock ranges from a low of $3.00 to a high of $25. The average analyst price target of $10.13 forecasts a 723.58% increase in the stock price over the next year.
Price Target: $10.13 (+723.58%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 1 | 1 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +387.80% | Nov 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,932.52% | Nov 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $14 → $11 | Strong Buy | Maintains | $14 → $11 | +794.31% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,932.52% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,932.52% | Nov 12, 2025 |
Financial Forecast
Revenue This Year
2.88M
Revenue Next Year
23.95M
from 2.88M
Increased by 731.05%
EPS This Year
-0.31
from -1.26
EPS Next Year
-0.46
from -0.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.9M | 46.9M | ||||
| Avg | 2.9M | 24.0M | ||||
| Low | 2.1M | 10.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 1,526.0% | ||||
| Avg | - | 731.1% | ||||
| Low | - | 275.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.19 | -0.36 | ||||
| Avg | -0.31 | -0.46 | ||||
| Low | -0.57 | -0.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.